1. Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?
- Author
-
Amedeo Massacesi, Davide Soranna, Paolo Milani, Antonella Zambon, M. Setaccioli, Fulvio Bergamini, Ferdinando Bottoni, Stefania Moschini, Marco Antonio Pellegrini, Milani, P, Pellegrini, M, Massacesi, A, Moschini, S, Setaccioli, M, Soranna, D, Zambon, A, Bottoni, F, and Bergamini, F
- Subjects
Male ,Retinal Ganglion Cells ,Vascular Endothelial Growth Factor A ,0301 basic medicine ,Visual acuity ,genetic structures ,Visual Acuity ,Angiogenesis Inhibitors ,Neovascularization ,0302 clinical medicine ,Fibrosis ,Myopia ,Fluorescein Angiography ,External limiting membrane ,Neuroretina ,Ellipsoid zone ,medicine.diagnostic_test ,Fluorescein angiography ,Sensory Systems ,Bevacizumab ,Treatment Outcome ,medicine.anatomical_structure ,Intravitreal Injections ,Myopia, Degenerative ,Female ,medicine.symptom ,Tomography, Optical Coherence ,SD-OCT ,medicine.medical_specialty ,Fundus Oculi ,Myopic neovascularization ,Lesion ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Optical coherence tomography ,Ophthalmology ,medicine ,Humans ,Pathologic myopia ,Aged ,Retrospective Studies ,Retina ,business.industry ,Anti-VEGF ,Recovery of Function ,medicine.disease ,Choroidal Neovascularization ,eye diseases ,030104 developmental biology ,030221 ophthalmology & optometry ,sense organs ,Sensory System ,business ,Follow-Up Studies - Abstract
Purpose: To evaluate functional prognostic factors and neuroretinal changes after anti-vascular endothelial growth factor (VEGF) treatment in patients with naïve, recent myopic neovascularization (mCNV), as assessed by spectral-domain optical coherence tomography (SD-OCT). Methods: Specific changes in tomographic features between baseline and final follow-up were retrospectively evaluated by two examiners independently. Imaging was obtained by a multi-modal imaging system which combines fluorescein angiography and SD-OCT. Results: Twenty-two eyes (male, six; female, 16; mean age, 65 ± 14 years) were considered. Mean follow-up was 21.5 ± 14 months. Best-corrected visual acuity (BCVA) improved from 0.38 ± 0.26 to 0.16 ± 0.20 logMAR (p
- Published
- 2017
- Full Text
- View/download PDF